社会经济剥夺与类风湿关节炎患者对TNF抑制剂治疗反应降低及治疗持续性下降相关
研究纳入英国风湿病学会生物制剂注册库(BSRBR-RA)16 085例和BRAGGSS队列3 459例首次使用TNF抑制剂(TNFi)的类风湿关节炎患者,以多重剥夺指数评估社会经济剥夺程度。最剥夺组6个月DAS28较高且低疾病活动度达标率较低,因无效停药风险较高;调整生活方式因素后估计值普遍减弱。
要点
- 最剥夺组6个月DAS28较最不剥夺组高0.3单位(95%CI 0.22,0.37),低疾病活动度达标OR 0.76(95%CI 0.68,0.84)。
- 最剥夺组因无效停药风险较最不剥夺组高(HR 1.18;95%CI 1.12,1.25),而非因不良事件。
- 作者认为需改善生活方式因素以外的健康决定因素以解决社会经济不平等。
核心结论
- 社会经济剥夺与TNFi治疗反应降低相关。
- 作者认为需改善生活方式因素以外的健康决定因素以解决社会经济不平等。
研究设计与样本
- 纳入BSRBR-RA和BRAGGSS队列中首次使用TNFi的类风湿关节炎患者。
- 以多重剥夺指数将社会经济剥夺程度分为最剥夺20%、中间40%和最不剥夺40%三组。
- BSRBR-RA 16 085例(平均年龄56岁,女性76%),BRAGGSS 3 459例(平均年龄57岁,女性77%)。
- 采用回归模型比较6个月(BSRBR-RA)和3个月(BRAGGSS)的DAS28衍生结局,以最不剥夺组为参照。
- 在BSRBR-RA中采用Cox模型比较全因和特定原因停药风险,并额外调整生活方式因素(如吸烟、BMI)作为潜在中介。
主要发现
- BSRBR-RA中最剥夺、中间和最不剥夺组分别占18%、41%和41%;BRAGGSS中分别占22%、36%和41%。
- 未调整模型中,最剥夺组6个月DAS28较最不剥夺组高0.3单位(95%CI 0.22,0.37),低疾病活动度达标OR 0.76(95%CI 0.68,0.84)。
- 3个月DAS28(β=0.23;95%CI 0.11,0.36)和低疾病活动度(OR 0.77;95%CI 0.63,0.94)结果相似。
- 最剥夺组更可能停药(HR 1.18;95%CI 1.12,1.25),主要由无效而非不良事件驱动。
- 调整后的估计值普遍减弱。
关键数值与推荐
- 最剥夺组6个月DAS28较最不剥夺组高0.3单位(95%CI 0.22,0.37)。
- 最剥夺组6个月低疾病活动度达标OR 0.76(95%CI 0.68,0.84)。
- 最剥夺组3个月DAS28 β=0.23(95%CI 0.11,0.36)。
- 最剥夺组3个月低疾病活动度达标OR 0.77(95%CI 0.63,0.94)。
- 最剥夺组全因停药HR 1.18(95%CI 1.12,1.25)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 调整后的估计值普遍减弱,提示生活方式因素可能部分中介所观察到的关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association between socioeconomic deprivation and outcomes following TNF inhibitor (TNFi) treatment. METHODS: Individuals commencing their first TNFi in the British Society for Rheumatology Biologics Register for RA (BSRBR-RA) and Biologics in RA Genetics and Genomics Study Syndicate (BRAGGSS) cohort were included. Socioeconomic deprivation was proxied using the Index of Multiple Deprivation and categorized as 20% most deprived, middle 40% or 40% least deprived. DAS28-derived outcomes at 6 months (BSRBR-RA) and 3 months (BRAGGSS) were compared using regression models with the least deprived as referent. Risks of all-cause and cause-specific drug discontinuation were compared using Cox models in the BSRBR-RA. Additional analyses adjusted for lifestyle factors (e.g. smoking, BMI) as potential mediators. RESULTS: 16 085 individuals in the BSRBR-RA were included (mean age 56 years, 76% female), of whom 18%, 41% and 41% were in the most, middle and least deprived groups, respectively. Of 3459 included in BRAGGSS (mean age 57, 77% female), proportions were 22%, 36% and 41%, respectively. The most deprived group had 0.3-unit higher 6-month DAS28 (95% CI 0.22, 0.37) and were less likely to achieve low disease activity (odds ratio [OR] 0.76; 95% CI 0.68, 0.84) in unadjusted models. Results were similar for 3-month DAS28 (β = 0.23; 95% CI 0.11, 0.36) and low disease activity (OR 0.77; 95% CI 0.63, 0.94). The most deprived were more likely to discontinue treatment (hazard ratio 1.18; 95% CI 1.12, 1.25), driven by ineffectiveness rather than adverse events. Adjusted estimates were generally attenuated. CONCLUSION: Socioeconomic deprivation is associated with reduced response to TNFi. Improvements in determinants of health other than lifestyle factors are needed to address socioeconomic inequities.
引用
- Zhao SS, Rogers K, Kearsley-Fleet L, et al. Socioeconomic deprivation is associated with reduced response and lower treatment persistence with TNF inhibitors in rheumatoid arthritis. Rheumatology (Oxford). 2024. PMID: 37267152. doi:10.1093/rheumatology/kead261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。